Anavex Life Sciences Newsroom

H.C. Wainwright Maintains Anavex Life Sciences(AVXL.US) With Buy Rating, Maintains Target Price $40

Moomoo NewsNov 4 06:31 ET

Anavex Life Sciences Analyst Ratings

BenzingaNov 4 06:30 ET

Anavex Life Sciences: Buy Rating Driven by Promising Blarcamesine Developments and Market Expansion

TipRanksNov 4 06:17 ET

JonesTrading Maintains Anavex Life Sciences(AVXL.US) With Buy Rating, Maintains Target Price $15

Moomoo NewsOct 31 11:32 ET

Anavex Life Sciences Is Maintained at Buy by EF Hutton

Dow JonesOct 31 09:13 ET

Anavex Life Sciences Analyst Ratings

BenzingaOct 18 07:04 ET

H.C. Wainwright Maintains Anavex Life Sciences(AVXL.US) With Buy Rating, Maintains Target Price $40

Moomoo NewsOct 18 06:37 ET

Buy Rating Affirmed for Anavex Life Sciences Amid Promising Clinical Developments and Market Prospects

TipRanksOct 18 06:28 ET

Buy Rating on Anavex Life Sciences Amid Anticipated European Approval and Market Opportunity for Alzheimer's Drug Blarcamesine

TipRanksAug 7 06:41 ET

JonesTrading Maintains Anavex Life Sciences(AVXL.US) With Buy Rating, Maintains Target Price $15

Moomoo NewsAug 6 14:31 ET

Buy Rating on Anavex Life Sciences: Upcoming Catalysts and Positive Trial Outcomes Fuel Optimism

TipRanksAug 6 13:48 ET

Anavex Life Sciences Analyst Ratings

BenzingaAug 1 06:13 ET

Buy Rating Affirmed for Anavex Life Sciences on Blarcamesine's Promising Alzheimer's Treatment Potential

TipRanksJul 31 08:37 ET

H.C. Wainwright Maintains Anavex Life Sciences(AVXL.US) With Buy Rating, Maintains Target Price $40

Moomoo NewsJul 31 08:31 ET

JonesTrading Maintains Anavex Life Sciences(AVXL.US) With Buy Rating, Maintains Target Price $15

Moomoo NewsJul 29 08:31 ET

Buy Rating Affirmed: Anavex Life Sciences' Promising Alzheimer's Drug Shows Potential for Approval

TipRanksJul 29 08:21 ET

Anavex Life Sciences Analyst Ratings

BenzingaJul 29 07:26 ET

Anavex Life Sciences Analyst Ratings

BenzingaJul 22 08:23 ET

Anavex Life Sciences Analyst Ratings

BenzingaJun 11 06:10 ET

Anavex Life Sciences Analyst Ratings

BenzingaMay 10 07:54 ET